From genome to bedside: are we lost in translation?

Hayes DF. From genome to bedside: are we lost in translation? Breast. 2013 Aug; 22 Suppl 2:S22-6.

View in: PubMed

Antineoplastic Agents, Hormonal
Biomarkers, Tumor
Breast Neoplasms
Case-Control Studies
Chemotherapy, Adjuvant
Combined Modality Therapy
Female
Genome
Humans
Mastectomy
Neoplasm Invasiveness
Neoplasm Staging
Patient Care
Patient Selection
Precision Medicine
Prognosis
Prospective Studies
Risk Assessment
Sensitivity and Specificity
Survival Analysis

Daniel Hayes

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement